How reliable are at-home gut microbiome tests?
Since gut microbiota appears to be linked to our health, many of us may be tempted to take a home test to learn more about the tiny world it harbors. This test may seem like an appealing way to explore one’s gut flora, its diversity and its microbiota. But the reliability of such tests leaves a lot to be desired…
- Learn all about microbiota
- Microbiota and related conditions
- Act on your microbiota
- Publications
- About the Institute
Healthcare professionals section
Find here your dedicated sectionSources
This article is based on scientific information
About this article
After the genetic testing trend, a new wave of self-testing is emerging: gut microbiome tests.
The idea is simple: analyze the bacteria present in your intestines from a stool sample collected using a testing kit and sent by mail.
27% Around 1 in 4 people surveyed (27%) had already heard about microbiome testing. ¹
60% 6 out of 10 respondents would be willing to have their gut microbiota tested as part of a general health checkup (61%), while 23% would do so out of curiosity. ¹
You directly receive a “gut health profile,” without having to see a doctor, to detect any potential dysbiosis. In other words, these bacteria are used as indicators thought to reflect the balance of the gut flora.
A booming market driven both by recent scientific discoveries highlighting the links between the microbiota and various digestive and metabolic diseases, such as obesity or certain cancers, as well as mental health disorders, but also its essential role in immune system development—not to mention the misinformation spread on social media.
All in a climate of confusion between at-home self-tests and research on medical tests in clinical settings.
+7.7% per year
The global self-testing market (all tests combined) was valued at $21.9 billion in 2025.
It is expected to grow from $23.7 billion in 2026 to $46.1 billion in 2035, representing an annual growth rate of 7.7%. 2
Unreliable results
Are these at-home tests reliable? A team of researchers 3 set out to check this by evaluating seven commercial services. To do this, they used a standardized stool sample—the kind laboratories typically use as a reference—and sent it three times to each company, using each complete kit according to the provided instructions, just as a consumer would before sending it to the lab.
The results should discourage you from investing in these tests! There are many flaws:
- analytical methods vary significantly from one company to another at every stage, from sample collection procedures to the computer-based analysis of results and the assessment of gut microbiota composition.
- results vary significantly from one company to another: only one bacterial genus (Streptococcus) was found by all companies. In some cases, the differences were comparable to the natural variations seen between individuals! Even more surprising, a same company sometimes obtained different results from the same sample sent three times for analysis.
- regarding result interpretation, each company uses its own benchmarks. The result: findings can vary from one provider to another—or even within a same company, which may deem a same profile “healthy” in one analysis and “unhealthy” in the next! This leads to contradictory recommendations, which are nonetheless presented as “personalized” in the report provided to consumers.
20% Only 2 out of 10 respondents (20%) would have their gut microbiota tested to help balance their microbiota, or to prevent or slow the progression of disease. ¹
31% 3 out of 10 participants (31%) would be willing to have their microbiota tested to help advance microbiota science. ¹
Call for caution and improvement
These discrepancies pose a serious problem, with the risk of delayed diagnosis for patients seeking answers, who might self-medicate based on misinformation, particularly when trying to better understand certain illnesses or a persistent intestinal disorder.
It is important to remember that age, diet, lifestyle and use of medications or probiotics all have a significant impact on the microbiota. Since these numerous factors are constantly changing, at-home microbiome tests taken at a single point in time cannot reliably determine whether microbiota is “good” or “bad,” nor can they yield relevant medical conclusions.
Furthermore, as consumer demand continues, the study’s authors are calling for several improvements to ensure that a simple test kit result is not treated as a medical diagnostic tool:
- improve analytical quality,
- exercise caution when interpreting results,
- and establish common guidelines for the entire sector (from testing companies to all potential partners involved).
The aim: to standardize practices and restore confidence among both users and health authorities.
Self-testing vs. medical testing: do not confuse the two!
There are two types of microbiome tests available on the market, and they should not be confused: direct-to-consumer tests (self-tests or at-home tests), and traditional diagnostic tests performed in a medical setting.
This distinction is based on several key points:
- how data is collected and accessed: at-home tests allow consumers to collect their own samples, send them to a laboratory, and access the results without the involvement of a clinician. In contrast, traditional medical tests are performed by trained healthcare professionals.
- level of regulatory oversight: at-home tests are not subject to the same level of oversight as traditional medical diagnostic tests when it comes to the validation of their analytical performance. Self-tests fall somewhere between strictly regulated medical devices and general wellness products, which are subject to much less regulation.
- clinical validation: unlike tests conducted in a medical setting, where validation is crucial to ensuring the reliability of results for clinicians and patients, at-home tests often lack the validation necessary for sound clinical decision-making.
- current regulatory status: as of early 2026, no clinical microbiome diagnostic test is approved by regulatory authorities in the United States, and the only sequencing-based test with CE marking in Europe is publicly discouraged by the French Society of Microbiology.
At-home tests are therefore considered “personal wellness” services that, unlike medical tests, are not subject to the analytical and clinical validation standards required for them to be reliable diagnostic tools. In response to these self-tests, microbiota researchers and clinicians urge the utmost caution.